Research Supply Standards Quality, fulfillment, and documentation indicators displayed to support buyer confidence
"For several years now, we've had a strategy to talk to our customers about treating people as people, not as diseases, realizing that, unfortunately, they have multiple conditions or diseases going on at one time, and that multiprogram platform approach has allowed us to actually sell more programs into a single customer." Omada Health, which went public in June, also tightened the bottom line, reducing its net loss to $3 million, or an adjusted loss of 6 cents per share, compared to a loss of $9 million in the third quarter of 2024
Critical for antioxidant defense
J Cardiovasc Dev Dis 7:59
Each episode jolts the body into wakefulness, fragmenting sleep and depriving sufferers of the deeper stages essential for restoration
Attenuating effects of Ganoderma lucidum polysaccharides on myocardial collagen cross-linking relates to advanced glycation end product and antioxidant enzymes in high-fat-diet and streptozotocin-induced diabetic rats
